PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for November 8, 2008 Subscribe to this News Feed    
 

Alcon Sponsors Online Educational Initiative for Patients Considering Cataract Surgery

Cataract Surgery Patients can Better Understand Their Condition at CataractSurgery.com

Fort Worth, Texas (PRWEB) November 8, 2008 -- Cataract surgery patients and their caregivers now have a new online educational resource to gather information on cataracts, found at www.cataractsurgery.com. Cataracts affect nearly 20 million Americans age 60 and older and are the leading cause of treatable blindness in the world. The new website is sponsored by Alcon, Inc. (NYSE:ACL), the world's leading eye care company, which has focused on preserving, restoring and enhancing sight for more than 60 years.

CataractSurgery.com
CataractSurgery.com

"Increasingly, we find that our patients and their families are looking to the Internet for information on healthcare," said Stephen Lane, M.D. and Clinical Professor of Ophthalmology for the University of Minnesota. "CataractSurgery.com will improve communication between the patient, the physician and the practice staff, as well as allow patients to have a clearer understanding of their surgical options."

The Alcon-sponsored educational website provides information on cataracts, cataract surgery and intraocular lens (IOL) options. In addition, CataractSurgery.com includes details on preparing for an eye exam and features videos, cataract illustrations, patient testimonials and a cataract resource library.

"Our research shows that there is a need for an informational website to help patients have better discussions with their eye care professionals, and increase their understanding of cataract surgery and IOL options prior to surgery," said Steve Speares, vice president, global cataract marketing. "CataractSurgery.com will help cataract patients feel comfortable about their cataract procedure options and give them confidence to make the best choice."

A Spanish language version of the website is scheduled to be available in the first half of 2009.

About Cataract Surgery
A cataract is a "clouding" of the eye's natural lens, which results in blurred or defocused vision. IOLs are implanted during cataract surgery to replace the patient's natural lens that has been removed during surgery. Cataract surgery is the most frequently performed surgery in the world today with surgeons around the world performing more than 15 million cataract surgeries annually. Cataracts cannot be prevented and are the leading cause of treatable blindness worldwide. For more information on cataract surgery visit http://www.cataractsugery.com.

About Alcon
Alcon, Inc. is the world's leading eye care company, with sales of approximately $5.6 billion in 2007. Alcon, which has been dedicated to the ophthalmic industry for over 60 years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1UaGlyLUhhbGYtUGlnZy1UaGlyLVNpbmctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Holly Clark
Alcon
800-631-0962
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move